Pharma Journalist -

CStone Pharmaceuticals announced that it has received approval to initiate clinical development in China of CS1001 in combination with BLU-554 (CS3008) in patients with locally advanced…
Read More...

Reata Pharmaceuticals, Inc. announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to bardoxolone methyl (bardoxolone) for the treatment of…
Read More...

Evotec SE announced that its strategic alliance with Celgene Corporation has been expanded to include a new cell type triggering a payment of $ 9.0 m to Evotec. Evotec and Celgene…
Read More...

SMi reports: Registration is now open for the 3rd annual Ophthalmic Drugs Conference and Focus Day, taking place in London this November The global ophthalmic drug market size is…
Read More...

Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following…
Read More...

Cambrex Corporation announced that it has completed a new 600 m2 facility at its site in Karlskoga, Sweden, which incorporates new laboratories for process and analytical development.…
Read More...

Enable Injections, Inc., a company developing and manufacturing advanced wearable infusion devices for combination products, announced it has entered into a multi-product development…
Read More...

Abveris, Inc., a leader in contract research antibody discovery, announced that it has entered into a multi-target agreement with TetraGenetics, Inc. a biopharmaceutical company…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for the investigational fixed-dose combination tablet of empagliflozin, linagliptin and metformin…
Read More...

GlaxoSmithKline announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending two new methods for…
Read More...